Free Trial

KP Tissue (TSE:KPT) Hits New 1-Year Low After Analyst Downgrade

KP Tissue logo with Consumer Defensive background

KP Tissue Inc. (TSE:KPT - Get Free Report)'s stock price hit a new 52-week low during trading on Wednesday after CIBC lowered their price target on the stock from C$9.00 to C$8.50. The company traded as low as C$7.98 and last traded at C$8.05, with a volume of 14343 shares changing hands. The stock had previously closed at C$8.05.

Insider Activity

In related news, Director Mario Gosselin sold 18,000 shares of KP Tissue stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of C$8.19, for a total transaction of C$147,420.00. Insiders own 0.14% of the company's stock.

KP Tissue Stock Down 0.2 %

The stock has a market cap of C$80.06 million, a P/E ratio of 13.38, a P/E/G ratio of -0.88 and a beta of 0.37. The company's 50 day moving average price is C$8.21 and its two-hundred day moving average price is C$8.35.

KP Tissue Company Profile

(Get Free Report)

KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.

Featured Stories

Should You Invest $1,000 in KP Tissue Right Now?

Before you consider KP Tissue, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.

While KP Tissue currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines